课题基金 / 基金详情

DEFINING THE HCV INFECTIOUS WINDOW PERIOD IN THE CHIMPANZEE

DEFINING THE HCV INFECTIOUS WINDOW PERIOD IN THE CHIMPANZEE
黑猩猩 HCV 感染窗口期的定义
批准号:
7349765
负责人:
KRISHNA H MURTHY
金额:
$1.27万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2007-04-30

项目摘要

项目成果

KRISHNA H MURTHY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The infectious window period for hepatitis C virus (HCV), the time between exposure to the virus and the first detection of viral RNA, is not well defined. By establishing the window period, the risk of transmission of HCV by blood products can be further reduced and or prevented. The objective is to define and characterize the infectious window period for HCV in the chimpanzee model. Two chimpanzees have been selected and baseline liver enzyme levels have been determined. HCV borderline positive and negative plasma panels are being put together for the proposed studies. One chimpanzee was IV infused with 50 ml of plasma from each of five individual donors from a panel negative for HCV by nucleic acid testing (NAT). The animals become infected indicating that HCV was present below the level of detection of NAT. Additional virological and immunological assays are being performed at the represent time. Virological assays indicated that the animal rapidly cleared the infection and did not seroconvert. The planned inoculation of the second animal is on hold until a final decision is made on using a different plasma panel.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEFINING THE HCV INFECTIOUS WINDOW PERIOD IN THE CHIMPANZEE
CHIMPANZEES FOR HEPATITIS OR AIDS RESEARCH
IMMUNOGENICITY OF HIV CANDIDATE VACCINES IN BABOONS
NEOANTIGENICITY OF RIBOFLAVIN AND LIGHT TREATED RBCS IN BABOONS
国内基金
海外基金
三种凤尾蕨属植物中吡咯生物碱及其抗菌和抗HCV病毒功能研究
  • 批准号:
    82360689
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32.00万元
  • 批准年份:
    2023
  • 负责人:
    邹娟
  • 依托单位:
KIR/HLAI基因遗传变异及HCV逃逸突变与感染免疫应答相关性的分子流行病学及机制研究
  • 批准号:
    82273691
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    岳明
  • 依托单位:
基于“逆向免疫学”理论筛选具有交叉保护作用的抗HCV抗原表位的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    边中启
  • 依托单位:
云南省HCV感染人群C19orf66基因遗传易感性分析及其机制研究
  • 批准号:
    32160148
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    34万元
  • 批准年份:
    2021
  • 负责人:
    张阿梅
  • 依托单位: